SCHEMBL22817733

SCHEMBL22817733

c1ccc(-c2cccc(-c3cc4c(oc5cccc(N(c6ccccc6)c6ccccc6)c54)c4ccccc34)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.36
▸ PLA2G2A P14555 3/20 0.35
▸ PLA2G4A P47712 3/20 0.35
▸ PRKDC P78527 2/20 0.33
▸ PLA2G10 O15496 1/20 0.33
▸ GGPS1 O95749 1/20 0.32
▸ CDK1 P06493 1/20 0.31
▸ CCNB1 P14635 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ CDK5 Q00535 1/20 0.31
▸ CDK5R1 Q15078 1/20 0.31
▸ EPHX2 P34913 1/20 0.31
▸ CDC14B O60729 1/20 0.30
▸ CDC14A Q9UNH5 1/20 0.30
▸ PTGES2 Q9H7Z7 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ CSF1R P07333 1/20 0.30
▸ PDGFRB P09619 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ KIT P10721 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26486654 0.99 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22817697 0.97 ALOX5 (0.35) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22817687 0.97 ALOX5 (0.38) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22818356 0.97 ALOX5 (0.38) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL26486655 0.96 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22818352 0.96 ALOX5 (0.37) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22817845 0.96 ALOX5 (0.39) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22818002 0.96 ALOX5 (0.39) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22818003 0.95 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APRKDCPLA2G10
SCHEMBL22817846 0.95 ALOX5 (0.36) ALOX5PLA2G2APLA2G4APRKDCPLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885PLA2G2A 4271/4885PLA2G4A 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback